Coordinating Pragmatic Primary Care Population Management for Obesity

Author(s):  
2020 ◽  
Author(s):  
MD Deborah Blazey-Martin ◽  
FNP Elizabeth Barnhart ◽  
Joseph Gillis ◽  
Gabriela Andujar Vazquez

Abstract BACKGROUND: Most patients infected with SARS-CoV-2 have mild to moderate symptoms manageable at home; however up to 20% develop severe illness requiring additional support. Primary care practices performing population management can use these tools to remotely assess and manage COVID-19 patients and identify those needing additional medical support before becoming critically ill.AIM: We developed an innovative population management approach for managing COVID-19 patients remotely.SETTING: Development, implementation, and evaluation took place in April 2020 within a large urban academic medical center primary care practice.PARTICIPANTS: Our panel consists of 40,000 patients. By April 27, 2020, 305 had tested positive for SARS-CoV-2 by RT-qPCR. Outreach was performed by teams of doctors, nurse practitioners, physician assistants, and nurses.PROGRAM DESCRIPTION: Our innovation includes an algorithm, an EMR component, and a twice daily population report for managing COVID-19 patients remotely.PROGRAM EVALUATION: Of the 305 patients with COVID-19 in our practice at time of submission, 196 had returned to baseline; 54 were admitted to hospitals, six of these died, and 40 were discharged.DISCUSSION: Our population management strategy helped us optimize at-home care for our COVID-19 patients and enabled us to identify those who require inpatient medical care in a timely fashion.


2020 ◽  
Vol 35 (10) ◽  
pp. 3077-3080
Author(s):  
Deborah Blazey-Martin ◽  
Elizabeth Barnhart ◽  
Joseph Gillis ◽  
Gabriela Andujar Vazquez

AIDS ◽  
2000 ◽  
Vol 14 (3) ◽  
pp. 297-301 ◽  
Author(s):  
Emily J. Erbelding ◽  
David Stanton ◽  
Thomas C. Quinn ◽  
Anne Rompalo

2021 ◽  
pp. 1-11
Author(s):  
Danelly Rodríguez ◽  
Emmeline Ayers ◽  
Erica F. Weiss ◽  
Joe Verghese

Background: Very few studies have explored the utility of subjective cognitive complaints (SCCs) in primary care settings. Objective: We aim to investigate associations between SCCs (item-level), objective cognitive function (across domains and global), and mood in a diverse primary care population, including subjects with mild cognitive impairment. Methods: We studied 199 (75.9%females; 57.8%Hispanics; 42.2%African Americans) older adults (mean age 72.5 years) with memory concerns at a primary care clinic. A five-item SCC questionnaire, and objective cognitive assessments, including the Montreal Cognitive Assessment (MoCA) and the Geriatric Depression Scale, were administered. Results: Logistic regression analyses showed associations between SCC score and depressive symptoms. A memory-specific (“memory worsening”) SCC predicted scores on the MoCA (p = 0.005) in Hispanics. Conclusion: SCCs are strongly linked to depressive symptoms in African Americans and Hispanics in a primary care setting; a specific type of SCC is related to global cognitive function in Hispanics.


Cephalalgia ◽  
2014 ◽  
Vol 34 (11) ◽  
pp. 927-932 ◽  
Author(s):  
Antonia FH Smelt ◽  
Willem JJ Assendelft ◽  
Christel E van Dijk ◽  
Jeanet W Blom

Background Clinical trials on the prophylactic effect of propranolol and metoprolol for migraine show that starting this medication leads to a decrease in the use of attack medication of 0.9–8.9 doses per month. However, studies in daily practice are lacking. Methods We compared the number of triptans prescribed in the six months before and the six months after the start of propranolol/metoprolol in a Dutch national representative primary care cohort. Results Of the 168 triptan-using patients who started with propranolol or metoprolol, the number of triptans prescribed before starting was 4.6 doses per month. The number of triptans prescribed six months before compared with six months after starting propranolol/metoprolol decreased with 1.0 dose per month (Wilcoxon rank test; p = 0.000). Conclusion In this primary care population, although the number of triptans prescribed decreased after starting propranolol or metoprolol, the decrease is relatively small compared to data from clinical trials.


2011 ◽  
Vol 25 (1) ◽  
pp. 4-9 ◽  
Author(s):  
N. Ben Chaabane ◽  
N. El Jeridi ◽  
K. Ben Salem ◽  
O. Hellara ◽  
H. Loghmari ◽  
...  

2015 ◽  
Vol 18 (1) ◽  
pp. 23-29 ◽  
Author(s):  
Amanda G. Kennedy ◽  
Harry Chen ◽  
Michele Corriveau ◽  
Charles D. MacLean

Sign in / Sign up

Export Citation Format

Share Document